Market Cap 8.41B
Revenue (ttm) 11.70B
Net Income (ttm) -443.15M
EPS (ttm) N/A
PE Ratio 18.96
Forward PE 42.35
Profit Margin -3.79%
Debt to Equity Ratio 0.26
Volume 6,563,700
Avg Vol 6,320,658
Day's Range N/A - N/A
Shares Out 301.49M
Stochastic %K 35%
Beta 2.36
Analysts Sell
Price Target $26.44

Company Profile

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy,...

Industry: Healthcare Plans
Sector: Healthcare
Phone: 646 403 3677
Address:
75 Varick Street, 5th Floor, New York, United States
Jimmymc1337
Jimmymc1337 Aug. 10 at 9:08 PM
$OSCR has significant institutional ownership, including several major asset managers and hedge funds. Latest disclosed holdings show: BlackRock: ~17.3M shares Vanguard: ~21.3M shares across two reporting entities T. Rowe Price: ~11.6M American Century: ~7.0M Thrive Capital: ~6.3M D.E. Shaw: ~5.5M State Street: ~5.3M Geode: ~5.0M Citadel: ~3.5M Point72: ~3.1M Business Quant +1 There are also new institutional positions being reported. For example, Towle & Co. initiated roughly 278K shares (~$3.2M), while Empowered Funds initiated a position worth about $6.2M.
0 · Reply
Jimmymc1337
Jimmymc1337 Aug. 10 at 9:03 PM
$OSCR 🐂 $OSCR bull case is getting stronger. Revenue is surging, membership is approaching 3M, margins are improving, and management just raised 2026 operating earnings guidance to $500M$700M. Oscar is showing real operating leverage as it scales. If membership growth and margin expansion continue, $OSCR could have significant upside from here. 🚀
0 · Reply
Ashton_1nvests
Ashton_1nvests Aug. 10 at 6:05 PM
Three businesses I think look dramatically better than they did two years ago: $SOFI — more members, more products, stronger fee-based revenue and much better profitability. $ZETA — much larger revenue base, improving cash flow and margins, plus partnerships with companies like OpenAI, Snowflake and Palantir that make the AI opportunity much more interesting. $OSCR — the turnaround is showing up in the actual numbers now: better MLR, lower SG&A and real profitability. All three businesses look fundamentally stronger than they did a couple years ago.
0 · Reply
Jimmymc1337
Jimmymc1337 Aug. 10 at 4:38 PM
$OSCR once this hits 29$ we're going to the moon
0 · Reply
PeePeePantsCity
PeePeePantsCity Aug. 10 at 3:44 PM
$OSCR Lambos for everyone 🤣🤣🤣NOPE!
2 · Reply
markarchibald
markarchibald Aug. 10 at 3:35 PM
$OSCR StO 8/14 27/CSP for .34 #thewheel
0 · Reply
Jimmymc1337
Jimmymc1337 Aug. 10 at 2:30 PM
0 · Reply
PeePeePantsCity
PeePeePantsCity Aug. 10 at 11:27 AM
$OSCR It ain't over yet...Yikes🤣🤣🤣
1 · Reply
Mika10
Mika10 Aug. 10 at 1:37 AM
$OSCR $30 plus imminent.
0 · Reply
JFDI
JFDI Aug. 10 at 1:23 AM
$OSCR nice range low reclaim.
0 · Reply
Latest News on OSCR
Oscar Health price target raised to $26 from $20 at UBS

2026-08-07T13:11:54.000Z - 3 days ago

Oscar Health price target raised to $26 from $20 at UBS


Oscar Health price target raised to $27 from $19 at Baird

2026-08-07T12:01:31.000Z - 3 days ago

Oscar Health price target raised to $27 from $19 at Baird


Oscar Health price target raised to $39 from $35 at Barclays

2026-08-07T09:46:37.000Z - 3 days ago

Oscar Health price target raised to $39 from $35 at Barclays


Oscar Health price target raised to $25 from $13 at BofA

2026-08-06T17:40:19.000Z - 4 days ago

Oscar Health price target raised to $25 from $13 at BofA


Oscar Health price target raised to $39 from $35 at Barclays

2026-08-06T17:20:41.000Z - 4 days ago

Oscar Health price target raised to $39 from $35 at Barclays


Oscar Health Earnings Call Transcript: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 4 days ago

Oscar Health Earnings Call Transcript: Q2 2026


Oscar Health Earnings release: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 4 days ago

Oscar Health Earnings release: Q2 2026


Oscar Health Quarterly report: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 4 days ago

Oscar Health Quarterly report: Q2 2026


Oscar Health reports Q2 EPS $1.10, consensus 38c

2026-08-06T10:11:28.000Z - 4 days ago

Oscar Health reports Q2 EPS $1.10, consensus 38c


Oscar Health, Inc. to Host 2026 Investor Day

Jul 28, 2026, 8:00 AM EDT - 13 days ago

Oscar Health, Inc. to Host 2026 Investor Day


Oscar Health rises 15.0%

2026-06-04T16:08:17.000Z - 2 months ago

Oscar Health rises 15.0%


Oscar Health rises 12.1%

2026-06-04T14:06:50.000Z - 2 months ago

Oscar Health rises 12.1%


Oscar Health Transcript: AGM 2026

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Oscar Health Transcript: AGM 2026


Oscar Health up 2% to $20.81 after Wells Fargo upgrade

2026-06-04T09:30:08.000Z - 2 months ago

Oscar Health up 2% to $20.81 after Wells Fargo upgrade


Oscar Health Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Oscar Health Earnings Call Transcript: Q1 2026


Oscar Health Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Oscar Health Earnings release: Q1 2026


Oscar Health Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Oscar Health Quarterly report: Q1 2026


Oscar Health Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 3 months ago

Oscar Health Proxy statement: Proxy filing


Oscar Health Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 3 months ago

Oscar Health Proxy statement: Proxy filing


Meet Lucie. A New Way to Shop for Healthcare.

Apr 20, 2026, 6:00 AM EDT - 4 months ago

Meet Lucie. A New Way to Shop for Healthcare.


Oscar Health, Inc. 2026 First Quarter Earnings Conference Call

Apr 7, 2026, 8:00 AM EDT - 4 months ago

Oscar Health, Inc. 2026 First Quarter Earnings Conference Call


Oscar Health Tumbles: Can This Insurtech Disruptor Bounce Back?

Feb 25, 2026, 10:00 AM EST - 5 months ago

Oscar Health Tumbles: Can This Insurtech Disruptor Bounce Back?


Oscar Health Earnings Call Transcript: Q4 2025

Feb 10, 2026, 8:00 AM EST - 6 months ago

Oscar Health Earnings Call Transcript: Q4 2025


Oscar Health Annual report: Q4 2025

Feb 10, 2026, 8:00 AM EST - 6 months ago

Oscar Health Annual report: Q4 2025


Oscar Health Earnings release: Q4 2025

Feb 10, 2026, 8:00 AM EST - 6 months ago

Oscar Health Earnings release: Q4 2025


Oscar Health Revenue Rises, Eyes Profitability This Year

Feb 10, 2026, 7:38 AM EST - 6 months ago

Oscar Health Revenue Rises, Eyes Profitability This Year


Why This Health Care Stock Has Gained 35% This Week

Nov 26, 2025, 3:55 PM EST - 9 months ago

Why This Health Care Stock Has Gained 35% This Week


OSCR Stock Review: Strong Growth Meets Attractive Valuation

Nov 25, 2025, 9:35 AM EST - 9 months ago

OSCR Stock Review: Strong Growth Meets Attractive Valuation


Oscar Health Transcript: 7th Annual Healthcare Symposium

Nov 14, 2025, 9:50 AM EST - 9 months ago

Oscar Health Transcript: 7th Annual Healthcare Symposium


Oscar Health Transcript: UBS Global Healthcare Conference 2025

Nov 10, 2025, 4:15 PM EST - 9 months ago

Oscar Health Transcript: UBS Global Healthcare Conference 2025


Oscar Health Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 9 months ago

Oscar Health Earnings Call Transcript: Q3 2025


Oscar Health Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 9 months ago

Oscar Health Quarterly report: Q3 2025


Oscar Health Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 9 months ago

Oscar Health Earnings release: Q3 2025


Oscar Health, Inc. 2025 Third Quarter Earnings Conference Call

Oct 8, 2025, 6:00 AM EDT - 10 months ago

Oscar Health, Inc. 2025 Third Quarter Earnings Conference Call


Here's why the Oscar Health stock price is in a bull run

Oct 7, 2025, 11:03 AM EDT - 10 months ago

Here's why the Oscar Health stock price is in a bull run


Oscar Health Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Oscar Health Earnings Call Transcript: Q2 2025


Oscar Health Earnings release: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Oscar Health Earnings release: Q2 2025


Oscar Health Quarterly report: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Oscar Health Quarterly report: Q2 2025


Oscar Health: Should You Buy OSCR Stock At $17?

Jul 3, 2025, 9:05 AM EDT - 1 year ago

Oscar Health: Should You Buy OSCR Stock At $17?


How AI helped Oscar Health cut costs and grow

May 8, 2025, 6:35 PM EDT - 1 year ago

How AI helped Oscar Health cut costs and grow


Jimmymc1337
Jimmymc1337 Aug. 10 at 9:08 PM
$OSCR has significant institutional ownership, including several major asset managers and hedge funds. Latest disclosed holdings show: BlackRock: ~17.3M shares Vanguard: ~21.3M shares across two reporting entities T. Rowe Price: ~11.6M American Century: ~7.0M Thrive Capital: ~6.3M D.E. Shaw: ~5.5M State Street: ~5.3M Geode: ~5.0M Citadel: ~3.5M Point72: ~3.1M Business Quant +1 There are also new institutional positions being reported. For example, Towle & Co. initiated roughly 278K shares (~$3.2M), while Empowered Funds initiated a position worth about $6.2M.
0 · Reply
Jimmymc1337
Jimmymc1337 Aug. 10 at 9:03 PM
$OSCR 🐂 $OSCR bull case is getting stronger. Revenue is surging, membership is approaching 3M, margins are improving, and management just raised 2026 operating earnings guidance to $500M$700M. Oscar is showing real operating leverage as it scales. If membership growth and margin expansion continue, $OSCR could have significant upside from here. 🚀
0 · Reply
Ashton_1nvests
Ashton_1nvests Aug. 10 at 6:05 PM
Three businesses I think look dramatically better than they did two years ago: $SOFI — more members, more products, stronger fee-based revenue and much better profitability. $ZETA — much larger revenue base, improving cash flow and margins, plus partnerships with companies like OpenAI, Snowflake and Palantir that make the AI opportunity much more interesting. $OSCR — the turnaround is showing up in the actual numbers now: better MLR, lower SG&A and real profitability. All three businesses look fundamentally stronger than they did a couple years ago.
0 · Reply
Jimmymc1337
Jimmymc1337 Aug. 10 at 4:38 PM
$OSCR once this hits 29$ we're going to the moon
0 · Reply
PeePeePantsCity
PeePeePantsCity Aug. 10 at 3:44 PM
$OSCR Lambos for everyone 🤣🤣🤣NOPE!
2 · Reply
markarchibald
markarchibald Aug. 10 at 3:35 PM
$OSCR StO 8/14 27/CSP for .34 #thewheel
0 · Reply
Jimmymc1337
Jimmymc1337 Aug. 10 at 2:30 PM
0 · Reply
PeePeePantsCity
PeePeePantsCity Aug. 10 at 11:27 AM
$OSCR It ain't over yet...Yikes🤣🤣🤣
1 · Reply
Mika10
Mika10 Aug. 10 at 1:37 AM
$OSCR $30 plus imminent.
0 · Reply
JFDI
JFDI Aug. 10 at 1:23 AM
$OSCR nice range low reclaim.
0 · Reply
OnlyFibs
OnlyFibs Aug. 10 at 1:23 AM
$OSCR is seeing heavy institutional volume and high-beta momentum following record first-half profitability and a raised full-year 2026 earnings outlook. Looking at the options matrix, total net gamma sits positive at +3.2M (with total call gamma reaching +6.8M), towering +833.6K net gamma call wall directly at the $30.00 strike, hovering just above the current $27.90 spot price. As market makers actively hedge inside this expected range, smart money is tracking the key structural bounds closely. 🐂 🎯 Bull Key Levels: Reclaiming and holding a structural base above the $29.08 upper expected move boundary is essential to flip dealer hedging dynamics and unlock a fast move toward the $30.00 call wall. 🐂 🔥 Bear Key Levels: Slipping under the $26.72 lower expected move boundary removes the immediate positive gamma cushion and risks an accelerated drop toward the $27.50 put wall. 🐻 ⚠️ Take Profit Targets: $31.00 / $32.50. 💰 🎯 #hovdid
0 · Reply
EquityVoyager_1
EquityVoyager_1 Aug. 9 at 11:35 PM
THE “BUY & FORGET” WATCHLIST If I were building a long-term basket and willing to ignore the noise: $ASTS $NBIS $AAOI $OSCR The thesis: buy quality growth, stay patient, and let the story play out. These are the names I’d keep on the radar for the long haul. Another alert is coming soon. If notifications are off, chances are you’ll only notice the move once it’s already in progress.
0 · Reply
MarketPulsee
MarketPulsee Aug. 9 at 9:13 PM
STOCKS I THINK COULD 10X OVER THE NEXT DECADE $RCAT$9 $CIFR$17 $ASST$12 $ONDS$9 $OSCR$27 Why these names? They’re exposed to some of the biggest long-term themes I’m watching: AI infrastructure. Space. Defense. Robotics. Power. Software. Fintech. Next-generation technology. A 10X return doesn’t come from buying what’s already obvious. It comes from identifying businesses with massive addressable markets, strong execution, and enough runway to compound for years. Not every name will succeed. That’s the point of a 10-year watchlist. Which one has the potential to become the next generational winner? Follow my profile and check my homepage for more high-conviction ideas and long-term opportunities before they become crowded. NFA. DYOR.
2 · Reply
AICapitalLab
AICapitalLab Aug. 9 at 9:06 PM
$OSCR — a year ago, Bertolini's 2027 target was 20%+ revenue CAGR and a 5% operating margin. Fast forward: it's still 2026, and full-year revenue guidance already sits at $18.7-19B, way past where that plan had them for next year. Margin's tracking lower for now — guidance implies full-year operating margin near 3%, not 5% yet. Growth's outrunning the plan; profitability's still catching up.
0 · Reply
DeltaSigma
DeltaSigma Aug. 9 at 8:56 PM
I think $OSCR gets overlooked on claims experience. Faster processing and easier approvals can improve member satisfaction, while managing conditions earlier may reduce costly care later. If that leads to better retention and lower medical costs, it could become a real edge as ICHRA adoption grows.
0 · Reply
MarketScoutTrades
MarketScoutTrades Aug. 9 at 8:54 PM
25 Charts Just Dropped for Subscribers 📊 (Part 4) More setups making my watchlist: $ORCL $OSCR $PLTR $SERV $SOLS I’m watching the key breakout levels, upside targets and how each chart is behaving around important technical areas. Some setups may need patience, but I’d rather wait for the right confirmation than chase a move. Save this one and revisit it when the market gives us the next signal.
1 · Reply
ETAlpha
ETAlpha Aug. 9 at 8:44 PM
$OSCR Is Executing Ahead of Schedule CEO Mark Bertolini said a year ago that by 2027, $OSCR could reach roughly 5% EBIT margins and $14B in revenue. It’s still 2026, and the company already has 4.1% EBIT margins and $15.32B in revenue, meaning revenue has already surpassed that target. Fundamental execution is running ahead of schedule. If price holds key support while volume improves, the trend could strengthen further. The next key test is continued margin expansion. Check my profile for more market insights. Every update builds a bigger picture.
0 · Reply
NebulaNexus
NebulaNexus Aug. 9 at 8:04 PM
$OSCR crushing its 2027 revenue target ($15.3B vs $14B) a full year early while pushing EBIT margins to 4.1% proves CEO Mark Bertolini wasn't just selling a story. There's still a small 90 bps gap to hit the 5% margin goal, but delivering this far ahead of schedule builds real credibility—which is exactly why the market is willing to trust management here.
0 · Reply
NebulaNexus
NebulaNexus Aug. 9 at 6:58 PM
The ICHRA angle is what keeps me interested in $OSCR. Oscar estimates roughly 115M lives across the small-group and middle-market market, while Lucie could potentially cut employer costs by around 26% versus traditional plans. The TAM gets attention, but the savings are what could actually drive adoption. I want to see how quickly that turns into members and revenue.
0 · Reply
MarketScoutTrades
MarketScoutTrades Aug. 9 at 6:51 PM
My Long-Term Targets for Stocks I Like 🎯 | 3–5 Years (Part 2) Here’s the next group of names on my long-term radar: $AMD | $1,300 $OSCR | $110 $SOFI | $160 $ZETA | $180 $XPEV | $130 These are long-term targets based on where I think these businesses could potentially go over the next 3–5 years. I’m not expecting a straight line up — there will be volatility, pullbacks and plenty of noise along the way. For me, the key is staying focused on the bigger picture and reassessing the thesis as fundamentals evolve. Save this one and revisit it when the market gives us the next signal.
3 · Reply
FibonacciTrader_
FibonacciTrader_ Aug. 9 at 4:45 PM
$OSCR -Don’t chase this move. If you’re holding $OSCR, this is a level I’d be paying VERY close attention to. I believe Wave 1 is already complete, and we took profits with subscribers around $31. Now I’m watching for the Wave 2 pullback. My preferred accumulation zone is below $20. People ignored the last warning when I said $OSCR could revisit $12 - and we know how that played out. I’m expecting the same lesson again: patience > FOMO. Bookmark this. The next $OSCR entry may come much lower.
0 · Reply
MarlonJohn
MarlonJohn Aug. 9 at 4:35 PM
$OSCR Q2 earnings dropped a massive signal: 98.7% first-pass claims accuracy cleared in under 48 hours. This isn’t just a back-office metric, it’s a decade of proprietary tech stack execution. While others rely on third-party software, Oscar built tech directly into the product. SG&A hit a record low ~14%, improving over 1% YoY. Operating leverage is scaling fast as membership grows. My trading thesis says this structural efficiency is a massive hidden edge. How long before the market fully prices this in? More on my profile.
0 · Reply